Cytogenetics has not only precipitated the discovery of several oncogenes, but has also led to the molecular classification of numerous malignancies. The correct identification of aberrations in many tumors has, however, been hindered by extensive tumor complexity and the limitations of molecular cytogenetic techniques. In this study, we have investigated five malignant melanoma (MM) cell lines from at least three different passages using high-resolution R-banding and the recently developed methods of comparative genomic hybridization and multicolor or multiplex fluorescence in situ hybridization. We subsequently detected nine consistent translocations, seven of which were novel: dic(1;11)(p10;q14), der(9)t(3;9)(p12;p11), der(4)t(9;4;7) (q33Dp15-q23Dq21), der(14)t(5;14) (q12;q32), der(9) t(9;22)(p21;q11), der(19)t(19;20)(p13.3;p11), der(10) t(2;12;7;10)(q31Dp12!pterDq11.2!q 31Dq21), der(19)t(10;19)(q23;q13), and der(20)t(Y;20)(q11.23; q13.3). Furthermore, using the human HG-U133A GeneChip, positive expression levels of oncogenes or tumor-related genes located at the regions of chromosomal breakpoints were identified, including AKT1, BMI1, CDK6, CTNNB1, E2F1, GPNMB, GPRK7, KBRAS2, LDB2, LIMK1, MAPK1, MEL, MP1, MUC18, NRCAM, PBX3, RAB22A, RAB38, SNK, and STK4, indicating an association between chromosomal breakpoints and altered gene expression. Moreover, we also show that growth of all five cell lines can be significantly reduced by downregulating CDK6 gene expression with small interfering RNA (siRNA). Because the majority of these breakpoints have been reported previously in MM, our results support the idea of common mechanisms in this disease. Neoplasia (2005) 7, 303-311 
Introduction
Malignant melanoma (MM) is a fatal disease once metastasis has occurred and a dramatic increase in incidence has been recorded [1] . Despite successful identification of molecular mechanisms in many malignancies using cytogenetic data, MM still remains a challenging entity [2, 3] . To date, a recurrent involvement of chromosomes 1, 3, 6, 7, 9, 10, and 11 in MM has frequently been reported, although common cytogenetic aberrations with molecular characterization have yet to be defined [3, 4] .
Only recently, molecular cytogenetics has been shown to be effective in revealing complex cytogenetic events, even in MM [5] . For example, using fluorescently labeled DNA probes, fluorescence in situ hybridization (FISH) allows DNA copy number and the chromosomal location of a specific gene locus to be analyzed, thus revealing detailed information regarding translocations or DNA copy number changes [6] . The information provided by FISH is, however, limited to the precise location of the probe, leaving the majority of genomic changes undetected. In spite of this, multicolor or multiplex fluorescence in situ hybridization (M-FISH) and comparative genomic hybridization (CGH) identify cytogenetic abnormalities throughout the entire genome [7] . Using M-FISH, each human chromosome can be distinguished by a distinct color combination, allowing complex rearrangements to be identified [8] . CGH can determine the DNA copy number by hybridization of labeled tumor DNA (test) and normal DNA (reference) to normal metaphase chromosomes [9] . The ratios of fluorescence intensities on the chromosomes then reflect the copy number changes of corresponding sequences in the tumor DNA. Both methods do not require previous knowledge of genetic aberrations to evaluate the extent of genetic gains or losses in the genome. To gain the maximum benefit of whole genome analysis for structural as well as numeric aberrations in MM cells, we have combined M-FISH and CGH with CDD banding.
We then asked whether oncogenes located at these consistently found breakpoints were dysregulated in cells harboring the breakpoints. To gain the maximum benefit of whole genome analysis for chromosomal aberrations, as well as functional analysis on the mRNA level in MM cells, we have combined our comprehensive cytogenetic data with DNA microarray analysis. Strikingly, our results show that the majority of stable breakpoints identified are associated with increased oncogene expression levels when compared to MM cell lines without the aberrations, suggesting a direct relationship between chromosome aberrations and oncogenic development.
Materials and Methods

Cell Lines
The human melanoma cell lines A375, MelJUSO, and Skmel 28 were obtained from the ATCC (Manassas, VA), and 518A2 and 607B cells were a kind gift from Dr. P. Schrier (University of Leiden, Leiden, The Netherlands). All cells were cultured in DMEM (Gibco BRL, Paisley, UK) supplemented with 10% FCS and a 1% antibiotic -antimycotic mix (Gibco BRL) in a humidified 5% CO 2 -95% ambient air atmosphere at 37jC.
R-banding
Cells were harvested and fixed as previously described [10] . To obtain the most accurate information and high resolution of banding patterns, we applied chromomycin/ distamycin/DAPI (CDD) staining [11] . This method provides a high quality of reverse (R-) and 4V -6V-diamidino-2-phenylindole-2HCl (DAPI) banding in a single experiment. The karyotypes were classified using the International System for Human Cytogenetic Nomenclature ISCN 1995 as recommended by the International Standing Committee of Cytogenetic Nomenclature.
FISH and M-FISH
FISH was performed as described elsewhere [6] . As probes, BAC clone RP 11-888H2 containing the CDK6 gene and RP11-893C3 (4q21.21) was used to prove the involvement of the CDK6 gene in the marker t(4;7;9) in the 518A2 cell line.
For M-FISH, metaphase spreads were prepared overnight at room temperature and analyzed with M-FISH using the SpectraVysion 24-color karyotyping assay according to the manufacturer's protocol (Vysis, Downers Grove, IL). Metaphase images were captured with an epifluorescence microscope (Zeiss, Gö ttingen, Germany) equipped with a charged-coupled device (CCD) camera (Photometrics, Tucson, AZ) and using single-bandpass filters (SpectraVysion optical filters; Vysis) corresponding to the fluorophores SpectrumGold, SpectrumFRed, SpectrumAqua, SpectrumRed, SpectrumGreen, and the fluorescent DAPI counterstain. Further image processing and 24-color karyotyping were performed with the SpectraVysion Imaging System (Vysis). At least 10 metaphase spreads from each cell line were analyzed for M-FISH karyotyping.
CGH
Genomic DNA was isolated with the QIAamp DNA Blood Mini Kit (Qiagen, Valencia, CA) according to the manufacturer's instructions and stored at À20jC. Normal male reference DNA was obtained from Promega (Mannheim, Germany). Amplification by DOP polymerase chain reaction (PCR) and labeling of DNA samples were performed essentially as previously described [12] , and 1 -2 ml of the DOP-PCR product was used for PCR labeling with Dig-11-dUTP (tumor DNA) or Bio-16-dUTP (reference DNA) (Roche, Mannheim, Germany). Labeling was carried out in 50-ml reaction mixtures comprising 200 mM each of dATP, dCTP, and dGTP each; 160 mM dTTP; 40 mM Dig-11-dUTP or Bio-16-dUTP; 1% W1 detergent; 2 mM degenerate primer; and 0.1 U/ml Super Taq DNA Polymerase in TAPS buffer (25 mM TAPS, 50 mM KCl, 2 mM MgCl 2 , and 2.88 mM b-mercaptoethanol) for 5 minutes at 95jC, 30 cycles of 1.5 minutes at 94jC, 1.5 minutes at 58jC, and 3 minutes at 72jC, followed by a final extension at 72jC for 8 minutes. Equal amounts of tumor DNA and reference DNA-PCR products, along with a sufficient amount of human CotI DNA (Roche), were hybridized in Hybridisol (QBIOgene, Carlsbad, CA) on normal human metaphase slides (Vysis). For probe detection, a 1:200 dilution of anti -Dig-FITC (Sigma, St. Louis, MO) antibody and a 1:100 dilution of antiBiotin-Cy3 antibody (Sigma) were employed. After mounting with DAPI containing antifade solution (Vector Laboratories, Inc., Burlingame, CA), images were captured with a Leica DMRXA fluorescence microscope (Leica, Wetzlar, Germany) equipped with appropriate epifluorescence filters and a COHU CCD camera. CGH profiles were analyzed using Leica QFISH and the Leica QCGH software. Ten to 15 metaphases per case were analyzed to create the median ratio profile. Increases and decreases in DNA sequence copy numbers were defined by tumor-to-reference ratios of >1.2 and <0.8, and amplifications at ratios >1.4, respectively. These reference values were established before the study by CGH analysis of normal DNA samples from different sources as a specificity control, as well as different mixtures of male and female normal DNA and analyses of X-chromosome material as a sensitivity control. The mean green-to-red ratio of normal DNA was always between 0.8 and 1.2 on all chromosomes, with the exception of chromosomes 19, 22, and 1p32-pter [13] , which were not included in the analyses.
Gene Expression Profiling
Total RNA was isolated from MM cell lines using the Qiagen RNeasy Mini Kit (Qiagen) and subjected to DNA microarray analysis as described [14] . Briefly, 5 mg of total RNA was reverse-transcribed into double-stranded cDNA using the SuperScript Choice system (Invitrogen Corp., Carlsbad, CA). Biotinylated cRNA was prepared from ds cDNA by in vitro transcription using the BioArray IVT kit (Affymetrix, Santa Clara, CA), fragmented, and hybridized to HG-U133A microarray chips (Affymetrix) at 45jC for 16 hours in a rotisserie oven at 60 rpm. Arrays were washed using nonstringent buffer (6Â SSPE: 0.9 M sodium chloride, 0.06 M sodium phosphate, and 6 mM EDTA, pH 7.4) at 25jC, followed by a stringent buffer (100 mM MES, pH 6.7, 0.1 M NaCl, and 0.01% Tween 20) at 50jC, stained with streptavidinphycoerythrin (Molecular Probes, Eugene, OR), washed with 6Â SSPE, incubated with biotinylated antistreptavidin IgG, stained again with streptavidin -phycoerythrin, and washed again with 6Â SSPE. Arrays were scanned using the GeneArray scanner (Affymetrix). The images or measurements obtained were then transferred from the scanner to a specialized software (GeneChip software, MAS 5.0; Affymetrix) to analyze the expression profile of each mRNA species. Normalization was performed by global scaling, with the arrays scaled to an average intensity of 500. Normalized signal intensity values of genes located at the identified breakpoints in every MM cell line investigated were compared and visualized using the GeneSpringh software (Silicon Genetics, Redwood City, CA). Structural and functional information was extracted from the NetAffx website (http://www.affymetrix.com/analysis/index.affx), which details and annotates probesets on Affymetrix GeneChip microarrays. Sequence annotations include gene ontology (GO) terms and depiction of GO graph relationships; predicted protein domains and motifs; orthologous sequences; links to relevant pathways; and links to public databases including UniGene, LocusLink, SWISS-PROT, and OMIM.
Quantitative Real-Time Reverse Transcriptase PCR (RQ-PCR)
RQ-PCR was performed selectively for CDK6, LDB2, MP1, and PBX3. Total RNA was isolated as described above for analysis of gene expression profiling. Synthesis of cDNA and RQ-PCR was performed using TaqMan Reverse Transcription Reagents, TaqMan Universal Master Mix, and an ABI Prism 7700 Sequence Detection system according to the manufacturer's instructions (Applied Biosystems, Foster City, CA). Primers were purchased from Applied Biosystems. Relative gene expression was quantified using the comparative threshold cycle method and GAPDH as an internal standard.
Downregulation of CDK6 with siRNA
Two different siRNA molecules corresponding to exons 3 and 6 were purchased from Ambion, Inc. (Austin, TX). As a control, we used previously published 21-mer doublestranded siRNA molecules that are directed against firefly luciferase (5V-CGUUAUUUAUCGGAGUUGCAG-3V). The incubation of the cells with the siRNA was performed as described previously [15] . Briefly, 5 Â 10 3 cells were plated onto 24-well plates for cell growth analysis, and 10 5 cells onto six-well plates for expression analysis, transfected and harvested after 24 hours for detecting mRNA levels with RQ-PCR. For assessment of cell growth, cells were harvested 72 hours after siRNA treatment and counted with a Coulter Z1 counter (Coulter, Luton, Beds., UK).
Results
R-banding and M-FISH
All five MM cell lines showed abnormal karyotypes with near-triploid to tetraploid chromosome sets. At least six characteristic aberrations (i.e., abnormalities found in more than two cells per cell line) were identified in each cell line with R-banding alone (Table 1) . Together with M-FISH, 52 structural aberrations were detected also, confirming the cytogenetic findings by R-banding. From the 52 structural aberrations, 13 were centromeric translocations, eight of which involved the centromeric region of chromosome 1, engaging chromosomes 6 and 13 in two cell lines, followed by chromosomes 5, 6, 10, 14, 19, and 20, all affecting the individual centromeres. Other centromeric translocations included t(4;8), t(4;21), t(7;13), t(8;14), and t(14;15). Isochromosomes included chromosomes 4 and 8 in two cell lines, followed by chromosomes 1, 7, 10, 13, 14, 15, 21, and 22. Breakpoints outside the centromeric regions found in the majority of cells investigated (more than 50% of cells per cell line) included the regions: 2q31, 3p12, 4p15, 4q23, 5p14, 5q12, 7p15, 7q11, 7q21, 7q31, 9p11, 9p21, 9q33, 10p12, 10q23, 11q14, 11q23, 14q32, 17q21, 19p13.1, 19p13.3, 20p11, 20q11.2, 20q13.3, 22q11, and Yq11.34. Apart from centromeric translocations and isochromosomes, the most consistent aberrations (i.e., detectable in almost all cells throughout three passages) were: dic(1;11)(p10;q14), der(9)t(3;9)(p12;p11), der(4)t(9;4;7)(q33Dp15-q23Dq21), der(19)t(10;19)(q23;p13.1), der(14)t(5;14) (q12;q32), der(9) t(9;22)(p21;q11), der (19) (20) t(20;Y)(q13.3;q11.3) in Skmel 28, none of the identified aberrations has been published in MM cases previously. Additionally, another highly complex aberration could be detected, consisting of chromosomes 2, 7, and 10 according to M-FISH (Figure 1 ). The small insertion between the chromosomal materials 2 and 7 suggested that it contained chromosomal material derived from chromosome 18 or 19 according to M-FISH, although it could not be confirmed by whole chromosome painting. Instead, after careful revision of the raw images, the staining of the area concerned suggested the involvement of chromosome 12, which could then be confirmed by whole chromosome painting. Therefore, the retrospective banding annotation of this marker chromosome resulted in an isochromosome: der(10) t(2;12;7;10)(q31Dp12!pterDq11.2!q31Dq21). Each of the aberrations was (although the affected breakpoints were already being described in the past in other MM cell lines) characteristic for one cell line. To confirm the accuracy of the breakpoint annotations, we performed FISH at selected locations as illustrated in Figure 1 . der(1;5)(q10;q10) i(1q) der(11)t(1;11)(q41; q23) der(1;6)(p10;p10) der(1;16)(p10;q10) der(1;10)(p10;q10) der(1;20)(q10;q10) der(1;13)(p10;q10) der(1;14)(p10;p10) 2 del(2)(q11) -der(2;9)(p10;p10) -der(10)t(2;12;7;10) (q31Dp12!pterDq11.2!q31Dq21) der(17)t(2;17) (p16;q21) der(2;12)(p10;p10) der(2;19)(p10;p10) der(2)t(2;20)(q31;q11.2) 3 -del(3)(p22)x2 der(3;13)(q10; q10) der(9)t(3;9)(p12;p11) der(3)t(3;7)(q10;q33) der(3)t(3;10)(p22; q25) der(10)t(3;10)(p22; q25) 4 der(4;21)(q10;q10) -der(4;6)(p10;p10) --der(4)t(4;7)(q23;q21) der(4;8)(p10;q10) der(4)t(9;4;7)
(q32Dp15-q23Dq21) der(4;22)(q10;q10) 5 i(5q) der(5)t(5;7)(p14;p21) -der(5)t(5;14)(q12; q32) der(1;5)(q10;q10) der(5;11)(p10; q10) i(5q) 6 der(1;6)(p10;p10) -der(1;6)(q10;p10) --der(6;8)(p10;q10) der(4;6)(p10;p10) der(6;9)(p10;p10) 7 der(4)t(4;7)(q23;q21) der(5)t(5;7)(p14;p21) -der(7)t(7;21)(p15; q21) der(10)t(2;12;7;10) (q31Dp12!pterDq11.2!q31Dq21) der(4)t(9;4;7) (q32Dp15-q23Dq21) i(7p) der(3)t(3;7)(q10;q33) del(7)(q31) del(7)(q31) i(7p) der(7;13)(q10;q10) del(7)(q31) 8 --der(4;8)(p10;q10) -der(8;14)(q10;q10) 9 der(4)t(4;7)(q23;q21) der(9)t(9;22)(p21;q11) der(2;9)(p10;p10) der(9)t(3;9)(p12;p11) -der(4)t(9;4;7) (q32Dp15-q23Dq21) der(6;9)(p10;p10) der(9)t(9;13)(q10; q12) der(22)t(9;22)(q31; q11) 10 der(1;10)(p10;q10) der(10)t(10;13) (p12;q21) der(19)t(10;19) (q23;q13) der(3)t(3;10)(p22; q25) der(10)t(2;12;7;10) (q31Dp12!pterDq11.2!q31Dq21) del(10)(p12) der(10)t(3;10)(p22; q25) del(10)(p12) 11 -dic(1;11)(p10;q14) del(11)(p15) -der(11)t(1;11)(q41; q23) der(5;11)(p10;q10) der(11)t(1;11;1)(p32;q23;p32) 12 --der(2;12)(p10;p10) -i(12q) der(10)t(2;12;7;10) (q31Dp12!pterDq11.2!q31Dq21) 13 der(1;13)(p10;q10) der(1;13)(p10;q10) der(3;13)(q10;q10) der(7;13)(q10;q10) -i(13q)
der (10) 
CGH
Due to the complexity of the aberrations that were identified, we applied CGH to assess DNA copy number changes and to obtain the most detailed cytogenetic information ( Figure 2) . As previously described, regions 1p and 16p and chromosomes 19 and 22 were found to provide false-positive results and, therefore, were not included in our analysis. Generally, our CGH data were in good agreement with cytogenetic findings in MM [16] . Losses were frequently found on 2q, 4q, 6q, 8p, 9p, 10p, 10q21, 11q, chromosome 18, and 19q. Gains could be observed in regions 1q, 3q21, 5q, chromosome 7, 8q, 9q, chromosome 12, 14q, and chromosomes 17 and 20. These data show nonrandom DNA copy number changes shared by all five cell lines, characteristic of MM. Moreover, CGH detected chromosomal imbalances as a consequence of unbalanced translocations detected by R-banding and M-FISH for the following aberrations: der(4)t(9;4;7) in 518A2 cells; dic(1;11), der(9)t(9;22), and i(17q) in 607B cells; der(19)t(10;19) in A375 cells; der(9)t(3;9), der(3;13), der(14)t(5;14), i(7p), dic (17) , and der(9)t(9;22) in JUSO cells; and der(11)t(1;11;1) in Skmel28 cells.
Microarray
To study the functional consequences of the detected aberrations at the mRNA level, global gene expression profile of five MM cell lines was determined using the HG-U133A GeneChip interrogating approximately 22,000 unique sequences. As chromosomal aberrations such as translocations are known to lead to gene fusion or increased gene expression of oncogenes, we focused our investigation on the expression changes of oncogenes and other tumorassociated genes or genes that are known to be activated in tumors located at the identified breakpoints. We used the following approach. First, we determined the number of genes that showed elevated expression associated with a particular chromosomal aberration in a particular cell line when compared to cells that do not have this aberration. Next, we searched for oncogenes or other tumor-associated genes within this list using the publicly available gGene Ontology Mining Toolh (http://www.affymetrix.com/analysis/ index.affx). This software annotates Affymetrix Probe IDs according to their biologic or molecular function; however, manual literature search had to be added to achieve a reliable annotation of the full dataset. As a result, positive oncogene expression levels were found at 20 locations of chromosomal breakpoints-13 of which, detected stably in more than three passages, could be identified-when compared to cell lines lacking the same chromosomal breakpoints (Table 2 ). For example, in the 518A2 cell line, 7q21, which harbors the cyclin-dependent kinase 6 gene (CDK6), a member of the highly studied p16 pathway in MM, was involved in a consistent translocation der(4)t(9;4;7). Comparison of CDK6 expression levels in all five MM cell lines revealed a dominant expression level of CDK6 in 518A2 cells. CDK6 was also the only contributor downstream of p16 that showed the highest gene expression level in 518A2 cells in comparison to other cell lines studied. Additionally, candidate genes that showed the highest mRNA expression levels in the cell lines containing the breakpoint were: CTNNB1, E2F1, GPNMB, GPRK7, KBRAS2, LDB2, LIMK1, MAPK1, MEL, MP1, MUC18, NRCAM, PBX3, and RAB22A. CDK6, LDB2, MP1, and PBX3 gene expression levels were confirmed with RQ-PCR. AKT1, BMI1, RAB38, SNK, and STK4 also yielded positive results. However, expression levels were not as high when compared to other samples.
Downregulation of CDK6
CDK6, a component of the pRB pathway that operates downstream of the one in which the melanoma susceptibility gene p16 is involved, was expressed in all five MM cell lines. To examine its functional role, we downregulated its expression with small interfering RNA (siRNA) against exons 3 and 6 in separate experiments to ensure specificity of the ensuing effect. RQ-PCR analyses confirmed an up to five-fold reduction of the mRNA levels in all cell lines within 24 hours after exposure to either siRNA. In agreement with the known involvement of CDK6 in the G1 transition phase, this successful suppression concurred with an up to 70% reduction of cell growth within 72 hours (data not shown).
Discussion
Knowledge of cytogenetic changes leading to the deregulation of oncogene expression is rapidly growing not only in hematologic malignancies but also in solid tumors [4] . Although cytogenetic analysis of advanced MM is particularly challenging due to the complex nature and variability of chromosomal aberrations [3] , it is still possible that stable chromosomal changes that provide selective advantage to cells might be important in tumorigenic evolution. Because most of the breakpoints identified are being described in other MM cases as well, our results might provide insights into common mechanisms involved in MM evolution. So far, most cytogenetic studies concerning MM have been limited to a descriptive analysis of cytogenetic aberrations using various methods speculating about their functional consequences in terms of gene expression. Therefore, in this study, we asked whether changes in oncogenic expression at chromosomal breakpoints can be detected by comparing MM cell lines harboring the mutation versus cell lines lacking the breaks. The possible association of DNA copy number changes with gene expression levels will be presented separately.
The combination of the two most recent and sophisticated molecular cytogenetic techniques, CGH and M-FISH, with R-banding has shown to be very effective because each technique provided answers to different questions. Additionally, CGH proved to be successful in detecting DNA copy number changes caused by unbalanced translocations, confirming the results of M-FISH and R-banding (Figure 2) . These results are of value as confirmation of the structural aberrations detected, reflect the impact of these aberrations on the overall DNA copy number changes as a consequence, and confirm the clonality of the aberrations found. Therefore, these data contribute valuable results to the unique and emerging data arising from multicolor karyotyping and CGH.
We then asked whether cytogenetic aberrations had an effect on the expression level of the genes located at the chromosomal breakpoints. Using the global HG-U133A gene chip, we were able to detect positive as well as increased expression levels of oncogenes in 13 consistent breakpoints (i.e., breakpoints detectable in more than three passages in culture) in total 20 breakpoints identified in more than 50% of the cells per sample, compared to other cell lines deficient of the same breakpoints (Table 2) . These data provide valuable information in regard to potential targets for further molecular investigation.
We found a complex translocation, for example, involving a breakpoint at 7q21 in 518A2. Microarray expression analysis of this cell line revealed not only positive but also the highest mRNA expression level of the cyclin-dependent kinase gene located at 7q21, CDK6. With FISH using locusspecific probes, we could prove the involvement of the CDK6 gene in the translocation. Our functional analyses The signal range was calibrated for each gene individually to allow visualization of gene expression differences among the five cell lines. The normalized signal intensity value of each individual gene is quoted. The color bar is a qualitative indicator of signal intensity for a particular gene across the five cell lines and ranges from (no mRNA) detection result (blue) to high level mRNA expression (red). In the last column, reference is given to publications with melanoma cases harboring aberrations with the same breakpoint.
with siRNA further corroborate the growth-promoting potential of CDK6 in MM. In this context, it is interesting to note that researchers have recently reported elevated expression levels of the CDK6 locus in tumors developed in a p19 ARF -deficient mouse model [17] . Germline mutations in genes encoding several components of the retinoblastoma (RB) pathway, including the RB gene itself, have been positively correlated with a genetic predisposition to melanoma [18] [19] [20] . Our results are therefore not only in agreement with data obtained from the p19 ARF -deficient mouse model, but show for the first time that the proliferation of human melanoma cell lines can be suppressed with CDK6-targeted siRNA.
Other genes, such as RAB38, MAPK1, CTNNB1, GPNMB, NRCAM, MUC18, and E2F1, were reported to be overexpressed in human MM [21 -24] , confirming their role in the tumorigenesis. For the first time, our results show an association between these oncogene expression and the cytogenetically detectable breakpoints. It is interesting to note that the cell lines, deficient of the breakpoints at the locations of the oncogenes mentioned above, with the exception of RAB38, exhibited lower or a lack of mRNA expression. Other oncogenes that revealed higher expression levels in cell lines without breakpoints, such as SNK at 5q12, AKT1 at 14q32, and MEL at 19p13, may indicate that other mutations such as point mutations might be involved in the upregulation of these genes. These may include downstream effectors of transcriptional regulators. Another explanation could be the production of chimeric mRNA transcripts, leading to positive mRNA detection but overall reduced intensity. In either case, our findings support the involvement of the oncogenes mentioned above and the idea of clonal evolution due to these cytogenetic aberrations.
The existence of breakpoints without evident expression of tumor-related genes as seen for 20p11 in 518A2, 5p14 and 9p21 in 607B, or 10q23 in A375 may be due to different reasons. Other than the possibility of nonsignificant aberrations without any biologic role, they could still reflect the possibility of new and unknown genes at the regions affected. The most recent and comprehensive human gene expression analysis chip HG-U133A encompassing more than 22,000 genes still represents at least half of the estimated number of genes comprising the human genome [25, 26] . Although our current knowledge of genes is likely to be biased toward disease-related genes, as has been demonstrated in the past, cytogenetics could still provide important information on otherwise unknown genes with a crucial role in tumor biology. For the marker chromosome t(4;7;9), the involvement of the suggested genes in translocations could be confirmed with FISH using BACs containing the candidate genes (data not shown). Therefore, the combination of molecular cytogenetic techniques and microarray might be helpful in identifying targets for further molecular studies.
Taken together, this approach has used M-FISH and CGH, in combination with high-resolution R-banding, to achieve the highest possible level of resolution in cytogenetics and found seven consistent marker chromosomes in the cell lines investigated. Even though these aberrations are new, the breakpoints have been previously reported in several other MM cases. The distinctive gene expression patterns of the cell lines-together with the stability of these aberrations and, in particular, the location and high expression levels of potentially tumor-relevant genes in the vicinity of the respective breakpoints and, last but not the least, our functional siRNA studies-provide a compelling, albeit indirect, evidence for a specific function of reciprocal rearrangements in MM.
